The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

(CTN News) – According to a statement that was released by Novavax on Wednesday, it appears that the Food and Drug ...

Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...

Moderna (NasdaqGS:MRNA) experienced a 10% share price increase, coinciding with broader market gains but slightly below the Nasdaq Composite's 5% rise. Despite the market being uplifted by strong ...

HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine By Stephanie Brown HealthDay Reporter FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and ...

the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, according to a report ...

FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation ...